BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9250445)

  • 1. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.
    Saleh TY; Cryer PE
    Diabetes Care; 1997 Aug; 20(8):1231-6. PubMed ID: 9250445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments.
    Raju B; Arbelaez AM; Breckenridge SM; Cryer PE
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2087-92. PubMed ID: 16492699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial.
    Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF
    Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic actions of alanine and terbutaline in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1124-30. PubMed ID: 8375242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes.
    Cooperberg BA; Breckenridge SM; Arbelaez AM; Cryer PE
    Diabetes Care; 2008 Dec; 31(12):2271-2. PubMed ID: 18782903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycaemia in intensively treated type 1 diabetes subjects.
    Axelsen M; Wesslau C; Lönnroth P; Arvidsson Lenner R; Smith U
    J Intern Med; 1999 Mar; 245(3):229-36. PubMed ID: 10205584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes.
    Taplin CE; Cobry E; Messer L; McFann K; Chase HP; Fiallo-Scharer R
    J Pediatr; 2010 Nov; 157(5):784-8.e1. PubMed ID: 20650471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nocturnal hypoglycemia in insulin-dependent diabetics].
    Verny C; Remy C; Sachon C; Bosquet F; Casanova S; Grimaldi A
    Presse Med; 1995 Sep; 24(26):1198-200. PubMed ID: 7567846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting nocturnal hypoglycemia in patients with type I diabetes treated with continuous subcutaneous insulin infusion.
    Schiffrin A; Suissa S
    Am J Med; 1987 Jun; 82(6):1127-32. PubMed ID: 3605131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
    Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
    Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
    Matyka KA; Crowne EC; Havel PJ; Macdonald IA; Matthews D; Dunger DB
    Diabetes Care; 1999 Jul; 22(7):1144-50. PubMed ID: 10388980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes.
    Campbell MD; Walker M; Trenell MI; Stevenson EJ; Turner D; Bracken RM; Shaw JA; West DJ
    Diabetes Care; 2014 Jul; 37(7):1845-53. PubMed ID: 24784832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.
    Hirsch IB; Smith LJ; Havlin CE; Shah SD; Clutter WE; Cryer PE
    Diabetes Care; 1990 Feb; 13(2):133-42. PubMed ID: 2190769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
    Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB
    Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy.
    Taira M; Takasu N; Komiya I; Taira T; Tanaka H
    Metabolism; 2000 Apr; 49(4):440-3. PubMed ID: 10778865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.